Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iTEP Colon: Immuno-PET Imaging in Metastatic Colorectal Cancer
NCT02587247Phase 2Completed
- Sponsor
- CHU de Nantes
- Start
- Mar 2016
- Primary completion
- Jan 2017
- Countries
- 1
01
Overview
A Phase 2 trial of 68 Ga-IMP-288 in metastatic colorectal cancer (mCRC), sponsored by CHU de Nantes. Started Mar 2016; status: completed.
02
Drugs
68 Ga-IMP-288
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02587247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02587247.